UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9773, pp. 1264 - 1275
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Viral diseases of the respiratory system and ent viral diseases | Infectious diseases | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Community-Acquired Infections - diagnosis | United States - epidemiology | Age Distribution | Pandemics | Age Factors | Community-Acquired Infections - epidemiology | Developing Countries - statistics & numerical data | Humans | Pneumonia, Viral - drug therapy | Lung - diagnostic imaging | Pneumonia, Bacterial - prevention & control | Specimen Handling | Lung - virology | Pneumonia, Viral - epidemiology | Adult | Immunocompetence | Child | Community-Acquired Infections - virology | Diagnosis, Differential | Lung - pathology | Pneumonia, Bacterial - microbiology | Global Health | Antiviral Agents - therapeutic use | Comorbidity | Pneumonia, Bacterial - epidemiology | Biomarkers - blood | Pneumonia, Bacterial - diagnosis | Radiography | Pneumonia, Viral - prevention & control | Pneumonia, Viral - diagnosis | Pneumonia, Viral - mortality | Pneumonia, Viral - virology | Causes of | Viral pneumonia | Care and treatment | Diagnosis | Pneumonia | Pathogenesis | Mortality | Severe acute respiratory syndrome | Industrialized nations | Viruses | Infections | Epidemiology | Avian flu | Developing countries--LDCs | Swine flu | Viral infections | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 06/2020, Volume 130, Issue 6, pp. 2757 - 2765
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Coronavirus Infections - prevention & control | Antibodies, Viral - therapeutic use | Risk Assessment | Pneumonia, Viral - therapy | United States | Humans | Pandemics - prevention & control | Antibodies, Viral - blood | Coronavirus Infections - immunology | Investigational New Drug Application | Betacoronavirus - immunology | COVID-19 | Immunization, Passive - adverse effects | Blood Donors | SARS-CoV-2 | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Pneumonia, Viral - prevention & control | Coronavirus Infections - therapy | Coronavirus Infections - blood | Antibodies, Viral - administration & dosage | United States Food and Drug Administration | Epidemics | Care and treatment | Severe acute respiratory syndrome | World health | Antibodies | Development and progression | Respiratory agents | Coronaviruses | Blood banks | Viral antibodies | Prevention | China | Health aspects | Maryland | Index Medicus | Abridged Index Medicus
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 08/2020, Volume 369, Issue 6506, pp. 956 - 963
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Antibody Specificity | Humans | Middle Aged | Pandemics - prevention & control | Antibodies, Monoclonal - therapeutic use | Male | Antibodies, Viral - blood | Viral Load | Betacoronavirus - immunology | COVID-19 | SARS-CoV-2 | Antibodies, Neutralizing - therapeutic use | Peptidyl-Dipeptidase A - metabolism | Protein Domains | Binding Sites | Antibodies, Monoclonal - immunology | Disease Models, Animal | Antibody Affinity | Epitopes | Coronavirus Infections - immunology | Antibodies, Viral - isolation & purification | Antibodies, Neutralizing - isolation & purification | Angiotensin-Converting Enzyme 2 | Coronavirus Infections - virology | Coronavirus Infections - therapy | Immunization, Passive | Spike Glycoprotein, Coronavirus - chemistry | Antibodies, Neutralizing - blood | Coronavirus Infections - prevention & control | Neutralization Tests | Antibodies, Monoclonal - blood | Antibodies, Neutralizing - immunology | Lung - virology | Betacoronavirus - physiology | Mesocricetus | Adult | Female | Spike Glycoprotein, Coronavirus - immunology | Cell Line | Spike Glycoprotein, Coronavirus - metabolism | Antibodies, Viral - therapeutic use | Pneumonia, Viral - therapy | Antibodies, Monoclonal - isolation & purification | Pneumonia, Viral - immunology | Animals | Virus Replication | Pneumonia, Viral - prevention & control | Antibodies, Viral - immunology | Pneumonia, Viral - virology | Prevention | Viral antibodies | Wildlife conservation | Analysis | Severe acute respiratory syndrome | World health | Antibodies | Coronaviruses | B cells | Health aspects | Antigenic determinants | Animal models | Model testing | Prophylaxis | Viral diseases | Animal diseases | Vaccines | Angiotensin-converting enzyme 2--ACE2 | Proteins | Receptors | Peptidyl-dipeptidase A | Public health | Spike protein | Hamsters | Severe acute respiratory syndrome coronavirus 2 | Domains | Neutralizing | Respiratory diseases | Angiotensin | Monoclonal antibodies | Binding sites | Neutralization | Index Medicus
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 07/2020, Volume 369, Issue 6499, pp. 77 - 81
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Coronavirus Infections - prevention & control | Immunogenicity, Vaccine | Dose-Response Relationship, Immunologic | Immunoglobulin G - blood | Rats, Wistar | Pandemics - prevention & control | Male | Macaca mulatta | Viral Vaccines - adverse effects | Antibodies, Viral - blood | Viral Load | Betacoronavirus - immunology | COVID-19 | Antibodies, Neutralizing - immunology | SARS-CoV-2 | Immunoglobulin G - biosynthesis | Immunoglobulin G - immunology | Female | Vero Cells | Antibodies, Viral - biosynthesis | Chlorocebus aethiops | Betacoronavirus - isolation & purification | Rats | Coronavirus Infections - immunology | Viral Vaccines - administration & dosage | Vaccines, Inactivated - adverse effects | Pilot Projects | Vaccines, Inactivated - immunology | Animals | Coronavirus Infections - virology | Vaccines, Inactivated - administration & dosage | Antibodies, Neutralizing - biosynthesis | Pneumonia, Viral - prevention & control | COVID-19 Vaccines | Antibodies, Viral - immunology | Mice | Mice, Inbred BALB C | Pneumonia, Viral - virology | Viral Vaccines - immunology | Antibodies, Neutralizing - blood | Medical research | Immunization | Pandemics | Severe acute respiratory syndrome | Viral diseases | Antibodies | Viruses | Infections | Monkeys | Vaccines | Coronaviruses | Dosage | Pharynx | Severe acute respiratory syndrome coronavirus 2 | Neutralizing | Respiratory diseases | Primates | Strains (organisms) | Public health | Index Medicus
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 07/2020, Volume 159, Issue 1, pp. 81 - 95
PRISMA | SARS | Fecal-to-Oral Transmission | Viral Persistence | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Betacoronavirus - pathogenicity | Coronavirus Infections - prevention & control | Endoscopy, Gastrointestinal - standards | Prevalence | COVID-19 Testing | Clinical Laboratory Techniques | Humans | Pandemics - prevention & control | Diarrhea - epidemiology | Infectious Disease Transmission, Patient-to-Professional - prevention & control | Viral Load | COVID-19 | Coronavirus Infections - transmission | Pneumonia, Viral - transmission | Feces - virology | SARS-CoV-2 | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | RNA, Viral - isolation & purification | Gastrointestinal Tract - virology | Betacoronavirus - isolation & purification | Coronavirus Infections - diagnosis | Diarrhea - virology | Diarrhea - diagnosis | Infection Control - standards | Gastrointestinal Tract - diagnostic imaging | Hong Kong - epidemiology | Pneumonia, Viral - prevention & control | Pneumonia, Viral - diagnosis | Betacoronavirus - genetics | Index Medicus | Abridged Index Medicus
Journal Article
Nature (London), ISSN 0028-0836, 08/2020, Volume 584, Issue 7821, pp. 425 - 429
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Coronavirus Infections - prevention & control | Prevalence | Asymptomatic Infections - epidemiology | Humans | Middle Aged | Pandemics - prevention & control | Betacoronavirus - enzymology | Child, Preschool | Infant | Male | Disease Outbreaks - statistics & numerical data | Viral Load | COVID-19 | Coronavirus Infections - transmission | Pneumonia, Viral - transmission | Young Adult | SARS-CoV-2 | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Aged, 80 and over | Adult | Female | Child | Infant, Newborn | Viral Envelope Proteins - genetics | RNA-Dependent RNA Polymerase - genetics | Betacoronavirus - isolation & purification | Coronavirus Envelope Proteins | Viral Nonstructural Proteins - genetics | Coronavirus RNA-Dependent RNA Polymerase | Coronavirus Infections - virology | Pneumonia, Viral - prevention & control | Adolescent | Disease Outbreaks - prevention & control | Italy - epidemiology | Aged | Betacoronavirus - genetics | Pneumonia, Viral - virology | Epidemics | Signs and symptoms | Demography | Statistical analysis | Severe acute respiratory syndrome | Viral diseases | Infections | Asymptomatic | Regions | Coronaviruses | Severe acute respiratory syndrome coronavirus 2 | Confidence intervals | Surveys | Disease transmission | Infectivity | Respiratory diseases | Population | Standard deviation | Age groups | Index Medicus
Journal Article
The Pediatric infectious disease journal, ISSN 0891-3668, 05/2020, Volume 39, Issue 5, pp. 355 - 368
SARS-CoV | Middle East respiratory syndrome coronavirus | MERS-CoV | Laboratory | Vaccines | Epidemiology | Prevention | Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Treatment | Imaging | Severe acute respiratory syndrome coronavirus | Symptoms | Pediatrics | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Coronavirus Infections - prevention & control | Severe Acute Respiratory Syndrome - epidemiology | Viral Vaccines - therapeutic use | Humans | Pandemics - prevention & control | Antibodies, Monoclonal - therapeutic use | Severe Acute Respiratory Syndrome - diagnosis | Middle East Respiratory Syndrome Coronavirus | COVID-19 | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Severe Acute Respiratory Syndrome - therapy | Disease Outbreaks | Protease Inhibitors - therapeutic use | Child | Nucleic Acid Synthesis Inhibitors - therapeutic use | Coronavirus Infections - diagnosis | Pneumonia, Viral - therapy | Vaccines, DNA - therapeutic use | SARS Virus | Severe Acute Respiratory Syndrome - prevention & control | Animals | Pneumonia, Viral - prevention & control | Coronavirus Infections - therapy | Pneumonia, Viral - diagnosis | Index Medicus | treatment | vaccines | imaging | symptoms | severe acute respiratory syndrome coronavirus | epidemiology | severe acute respiratory syndrome coronavirus 2 | laboratory | Special | prevention
Journal Article